Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesis
about
Nonalcoholic steatohepatitis: emerging targeted therapies to optimize treatment optionsClinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver diseaseUltrashort-TE stimulated echo acquisition mode (STEAM) improves the quantification of lipids and fatty acid chain unsaturation in the human liver at 7 T.Hepatic glucose and lipid metabolism.Desaturation index versus isotopically measured de novo lipogenesis as an indicator of acute systemic lipogenesisMUFAsAssociations of Erythrocyte Fatty Acids in the De Novo Lipogenesis Pathway with Proxies of Liver Fat Accumulation in the EPIC-Potsdam Study.Hepatic Steatosis as a Marker of Metabolic Dysfunction.Red Blood Cell Fatty Acids and Incident Diabetes Mellitus in the Women's Health Initiative Memory StudyExploring the Lean Phenotype of Glutathione-Depleted Mice: Thiol, Amino Acid and Fatty Acid Profiles.Impact of dietary fat on the development of non-alcoholic fatty liver disease in Ldlr-/- mice.Hepatic PPARγ Is Not Essential for the Rapid Development of Steatosis After Loss of Hepatic GH Signaling, in Adult Male MiceMetabolomic profiling to dissect the role of visceral fat in cardiometabolic healthCharacterization of long non-coding RNA transcriptome in high-energy diet induced nonalcoholic steatohepatitis minipigsCirculating FGF21 in humans is potently induced by short term overfeeding of carbohydratesEffect of high carbohydrate diet on elongase and desaturase activity and accompanying gene expression in rat's liverAlternation of plasma fatty acids composition and desaturase activities in children with liver steatosis.Stable isotope-based flux studies in nonalcoholic fatty liver disease.Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease.Free fatty acids profile among lean, overweight and obese non-alcoholic fatty liver disease patients: a case - control study.Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD.Association between Nicotinamide Phosphoribosyltransferase and de novo Lipogenesis in Nonalcoholic Fatty Liver Disease.Hepatic Steatosis is Common in Adolescents with Obesity and PCOS and Relates to De Novo Lipogenesis but not Insulin Resistance.Prevention of hepatic fibrosis with liver microsomal triglyceride transfer protein deletion in liver fatty acid binding protein null mice.Palmitic Acid: Physiological Role, Metabolism and Nutritional Implications.Hepatocyte-specific, PPARγ-regulated mechanisms to promote steatosis in adult mice.Growth Hormone Control of Hepatic Lipid Metabolism.Randomized Controlled Trial of a MUFA or Fiber-Rich Diet on Hepatic Fat in Prediabetes.Hepatic steatosis risk is partly driven by increased de novo lipogenesis following carbohydrate consumption.Gestational Diabetes Alters the Metabolomic Profile in 2nd Trimester Amniotic Fluid in a Sex-Specific MannerThiazolidinedione induces a therapeutic effect on hepatosteatosis by regulating stearoyl-CoA desaturase-1, lipase activity, leptin and resistinGluconeogenesis and risk for fasting hyperglycemia in Black and White women
P2860
Q26796448-86F9AF18-6962-4A94-9C29-113AF476BC75Q28072381-0103F441-6F7B-4D84-943C-8301C593D935Q30990361-91F4DAAF-B79F-48B3-8885-12528C194C8EQ31069203-C34F836D-4C59-4BB3-A09E-994631FD9736Q35132990-74CECB64-5065-439B-AB77-FB5AA0F49196Q35584643-E6F52FD2-7F40-4079-81ED-B1366872912FQ35619340-8B03F939-A424-48A9-988F-9659661705C6Q35809069-28279A5C-0F5F-41FE-A622-5790883E3C8BQ35924961-4EA6BB99-B084-44B7-8803-86735EF0B568Q36176054-805C47E6-141D-4B5D-9221-3423DFA72FD2Q36483906-C83C2AA6-89D2-420A-A8CE-890D34EF7008Q36911537-C347550F-6275-478C-AE7A-15123131108EQ37023957-A08D218A-8DFC-415D-8C4D-A7698E2D50BCQ37134791-3B1AB599-E932-4C75-A329-9A6FB0858DC4Q37571417-92D78453-9CAE-4133-98B9-E31794DA7F41Q37604662-6B508201-9505-4560-A6F7-D47D69CC46F3Q38651646-40FC3AE7-38CF-4CF4-925F-ACAB39282B11Q38655651-C5E81197-9E6B-4C20-ABB3-D588F26F1476Q39445103-268BECA6-4C81-43F7-87E3-A0CD7190352CQ41614727-8E28BEE5-B50C-4336-A013-124B59746E4FQ42172913-F0929A85-244D-4A99-B20B-D90BE3E19A3FQ42756198-DADB0D02-0BC4-4DE6-8BC3-5A34355AF7FDQ42759522-202F7CCC-B86A-4221-8E8D-C65E61230B5BQ46457925-9FB1E034-32CE-46B3-8DE1-4A0EB5607DDAQ46799280-0B904659-6707-47F5-9FB6-CAEFF6B361CDQ47152443-324F4670-36D2-4E2B-8D21-F70C1D41D721Q49329608-380A1AA6-D7F8-40C2-B84A-B645E94D552BQ50951947-05C4D8AE-21D1-4265-B134-0814B92470CFQ55315063-3C9B697E-7BB5-4486-A938-D1E87529C0D7Q57108635-595CB029-4A4B-4EED-ABD0-5D6C917F2859Q58802792-674A5ADE-C5E9-4963-A76A-98801C48B220Q59125552-61724D30-B99F-48DD-B4DC-A2CA605011F1
P2860
Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesis
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesis
@ast
Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesis
@en
type
label
Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesis
@ast
Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesis
@en
prefLabel
Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesis
@ast
Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesis
@en
P2093
P2860
P356
P1476
Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesis
@en
P2093
David A Wagner
Jennifer E Lambert
Joseph J Lee
Justin R Trombold
Maria A Ramos-Roman
Yelena Hovhannisyan
P2860
P356
10.3945/AJCN.114.092262
P407
P577
2014-11-19T00:00:00Z